Michael A. McManus Jr., Director at NOVAVAX INC (NVAX), bought 10,000 shares at $0.84 ($8K) on 2017-05-11, disclosed to the SEC on 2017-05-11.
Open-market purchase of $8k NVAX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| UAMY | BUY | 2024-08-15 | $51K | — | Filing → |
| NVAX | SELL | 2021-03-23 | $883K | — | Filing → |
| NVAX | SELL | 2020-08-20 | $1.2M | — | Filing → |